NASDAQ · ABLVW

Able View Global Inc.

$0.02 $0.00 (+0.00%) 1D Market open

Key Metrics

$658.90K
Market cap
0.80×
P/E · TTM
$105.20M
Revenue · TTM
$820.02K
Net income
EPS · TTM $0.02
Dividend yield 8.8%
Free cash flow $1.17M
Beta · 1Y -0.68
EBITDA · TTM −$642.46K
Gross margin 11.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 4
    The stock moved +26.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 4
  • Mar 30
    From its Feb 3 high, the share price fell 54%.

    Peak close $0.03 on Feb 3; trough close $0.02 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -54%
  • Mar 17
    The stock moved -29.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value−$6.17M
Shares outstanding
52-wk range$0.01 – $0.04
Avg volume · 20D33.1K
Net cash $6.83M
Book value / share$0.20
ExchangeNASDAQ
About Able View Global Inc.
IPO dateAug 18, 2023
Employees164

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E0.80
P/S0.01
P/FCF0.56
EV/EBITDA
EV/Sales-0.06
Graham №$0.30

Profitability

Gross 11.3%
Operating -0.7%
Net 0.8%
FCF 1.1%
ROE / ROIC 11.0% · -293.6%

Financial Health

Current ratio1.62
Quick ratio1.45
Debt / equity0.28
Debt / EBITDA -3.39
Net cash $6.83M
Working capital$12.34M

Cash Flow · TTM

Operating CF $1.20M
Capex −$27.17K
Free cash flow $1.17M
Buybacks $432.75K
Dividends paid $57.73K
Shareholder yield 74.4%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

3.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$0.30 vs $0.02
Trades below classic defensive value — Graham-cheap
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings